Skip to main content
SpringerLink
Log in

Immune thrombocytopenic pupura-induced reversible posterior leukoencephalopathy successfully treated by rituximab

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Fugate JE, Claassen DO, Cloft HJ, Kallmes DF, Kozak OS, Rabinstein AA (2010) Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc 85:427–432

    Article  PubMed  Google Scholar 

  2. Marinella MA, Markert RJ (2009) Reversible posterior leucoencephalopathy syndrome associated with anticancer drugs. Intern Med J 39:826–834

    Article  PubMed  CAS  Google Scholar 

  3. Min L, Zwerling J, Ocava LC, Chen IH, Putterman C (2006) Reversible posterior leukoencephalopathy in connective tissue diseases. Semin Arthritis Rheum 35:388–395

    Article  PubMed  Google Scholar 

  4. Hosoi M, Yamamoto G, Imai Y, Kurokawa M (2010) Reversible posterior leukoencephalopathy syndrome following R-CHOP therapy for diffuse large B-cell lymphoma. Ann Hematol 89:207–208

    Article  PubMed  Google Scholar 

  5. Zito JA, Lee CC, Johnson S, Singer A, Vacirca J (2010) Reversible posterior leukoencephalopathy syndrome after rituximab. Am J Emerg Med 28:537.e1–537.e2

    Article  Google Scholar 

  6. Westerweel PE, Verhaar MC (2009) Endothelial progenitor cell dysfunction in rheumatic disease. Nat Rev Rheumatol 5:332–340

    Article  PubMed  CAS  Google Scholar 

  7. Psaila B, Bussel JB (2008) Refractory immune thrombocytopenic purpura: current strategies for investigation and management. Br J Haematol 143:16–26

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology/Oncology, Department of Medicine, Taichung Veterans General Hospital, 160, Section 3, Chungkang Road, Taichung, 407, Taiwan

    Ching-Yeh Lin, Wen-Lee Hwang & Chieh-Lin Teng

  2. Department of Radiology, Taichung Veterans General Hospital, Taichung, Taiwan

    Hung-Chieh Chen

  3. Department of Life Science, Tunghai University, Taichung, Taiwan

    Chieh-Lin Teng

  4. Department of Medicine, Chung Shan Medical University, Taichung, Taiwan

    Chieh-Lin Teng

Authors
  1. Ching-Yeh Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hung-Chieh Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wen-Lee Hwang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chieh-Lin Teng
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chieh-Lin Teng.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lin, CY., Chen, HC., Hwang, WL. et al. Immune thrombocytopenic pupura-induced reversible posterior leukoencephalopathy successfully treated by rituximab. Ann Hematol 90, 731–732 (2011). https://doi.org/10.1007/s00277-010-1077-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-010-1077-z

Keywords

Search

Navigation